July 7, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alarum Technologies Ltd. (“Alarum” or “the Company”) (NASDAQ: ALAR). Investors who purchased Alarum securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alarum has violated… read more
July 7, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Identiv, Inc. (“Identiv” or “the Company”) (NASDAQ: INVE). Investors who purchased Identiv securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Identiv has violated federal… read more
July 3, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of InMode Ltd. (“InMode” or “the Company”) (NASDAQ: INMD). Investors who purchased InMode securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether InMode has violated federal… read more
July 2, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ON Semiconductor Corporation (“Onsemi” or “the Company”) (NASDAQ: ON). Investors who purchased Onsemi securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Onsemi has violated… read more
July 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SES AI Corporation (“SES” or “the Company”) (NYSE: SES). Investors who purchased SES securities prior to January 29, 2025, and continue to hold to the present, are encouraged to obtain additional… read more
July 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of LKQ Corporation (“LKQ” or “the Company”) (NASDAQ: LKQ). Investors who purchased LKQ securities prior to February 27, 2023, and continue to hold to the present, are encouraged to obtain additional information… read more
July 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alibaba Group Holding Limited (“Alibaba” or “the Company”) (NYSE: BABA). Investors who purchased Alibaba securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alibaba has… read more
July 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MercadoLibre, Inc. (“MercadoLibre” or “the Company”) (NASDAQ: MELI). Investors who purchased MercadoLibre securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether MercadoLibre has violated federal… read more
July 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Omeros Corporation (“Omeros” or “the Company”) (NASDAQ: OMER). Investors who purchased Omeros securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Omeros has violated federal… read more
July 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Ensign Group, Inc. (“Ensign Group” or “the Company”) (NASDAQ: ENSG). Investors who purchased Ensign Group securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
June 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alamos Gold Inc. (“Alamos” or “the Company”) (NYSE: AGI). Investors who purchased Alamos securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alamos has violated… read more
June 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DXC Technology Company (“DXC” or “the Company”) (NYSE: DXC). Investors who purchased DXC securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether DXC has violated… read more
June 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elastic N.V. (“Elastic” or “the Company”) (NYSE: ESTC). Investors who purchased Elastic securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Elastic has violated federal… read more
June 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GDS Holdings Limited (“GDS” or “the Company”) (NASDAQ: GDS). Investors who purchased GDS securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether GDS has violated… read more
June 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ARS Pharmaceuticals, Inc. (“ARS” or “the Company”) (NASDAQ: SPRY). Investors who purchased ARS securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether ARS has violated… read more
June 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Starfighters Space, Inc. (“Starfighters” or “the Company”) (NYSE: FJET). Investors who purchased Starfighters securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Starfighters has violated… read more
June 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Datavault AI Inc. (“Datavault” or “the Company”) (NASDAQ: DVLT). Investors who purchased Datavault securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Datavault has violated… read more
June 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hyliion Holdings Corp. (“Hyliion” or “the Company”) (NYSE: HYLN). Investors who purchased Hyliion securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Hyliion has violated… read more
June 25, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elicio Therapeutics, Inc. (“Elicio” or “the Company”) (NASDAQ: ELTX). Investors who purchased Elicio securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Elicio has violated… read more
June 25, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cerebras Systems Inc. (“Cerebras” or “the Company”) (NASDAQ: CBRS). Investors who purchased Cerebras securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Cerebras has violated… read more
June 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of JD.com, Inc. (“JD” or “the Company”) (NASDAQ: JD). Investors who purchased JD securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether JD has violated federal… read more
June 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Better Home & Finance Holding Company (“Better” or “the Company”) (NASDAQ: BETR). Investors who purchased Better securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
June 22, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NovoCure Limited (“Novocure” or “the Company”) (NASDAQ: NVCR). Investors who purchased Novocure securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Novocure has violated federal… read more
June 22, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accenture plc (“Accenture” or “the Company”) (NYSE: ACN). Investors who purchased Accenture securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Accenture has violated federal… read more
June 17, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gildan Activewear Inc. (“Gildan” or “the Company”) (NYSE: GIL). Investors who purchased Gildan securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Gildan has violated… read more
June 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Oxford Industries, Inc. (“Oxford” or “the Company”) (NYSE: OXM). Investors who purchased Oxford securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Oxford has violated… read more
June 15, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Borr Drilling Limited (“Borr” or “the Company”) (NYSE: BORR). Investors who purchased Borr securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Borr has violated… read more
June 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of United Homes Group, Inc. (“United Homes” or “the Company”) (NASDAQ: UHG). Investors who purchased United Homes securities prior to May 19, 2025, and continue to hold to the present, are encouraged… read more
June 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Kemper Corporation (“Kemper” or “the Company”) (NYSE: KMPR). Investors who purchased Kemper securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Kemper has violated federal… read more
June 11, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AECOM (“AECOM” or “the Company”) (NYSE: ACM). Investors who purchased AECOM securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether AECOM has violated federal securities… read more